Concepedia

A. David Rodrigues

AD

41

Publications

2.7K

Citations

31

H-Index

1987

Active since

Affiliations

Abbott (United Kingdom)(Current)

United States Military Academy

Abbott Fund

Bristol-Myers Squibb (United States)

Pfizer (United States)

A. David Rodrigues is an author at Abbott (United Kingdom) specializing in pharmacology, medicine, and biochemistry.

ORCID

Top concepts

Publications per year

1987–2023

41

Publications

41

Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes.

Gondi Kumar, A. David Rodrigues, Alex Buko et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 351 citations

GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS

Brian W. Ogilvie, Donglu Zhang, Wenying Li et al. · Drug Metabolism and Disposition · 2005 · 326 citations

Substrate inhibition kinetics for cytochrome P450-catalyzed reactions.

Yu-Chen Lin, Ping Lü, Cuyue Tang et al. · PubMed · 2001 · 154 citations

, , +12

Identification of the human P450 enzymes involved in lansoprazole metabolism.

Robin E. Pearce, A. David Rodrigues, Jorge Goldstein et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 148 citations

Interactions of imidazole antifungal agents with purified cytochrome P-450 proteins

A. David Rodrigues, G. Gordon Gibson, Costas Ioannides et al. · Biochemical Pharmacology · 1987 · 116 citations

, , +6

Rows per page

1–5 of 41